TSH RECEPTOR TRANSCRIPTS AND TSH RECEPTOR-LIKE IMMUNOREACTIVITY IN ORBITAL AND PRETIBIAL FIBROBLASTS OF PATIENTS WITH GRAVES OPHTHALMOPATHYAND PRETIBIAL MYXEDEMA
W. Stadlmayr et al., TSH RECEPTOR TRANSCRIPTS AND TSH RECEPTOR-LIKE IMMUNOREACTIVITY IN ORBITAL AND PRETIBIAL FIBROBLASTS OF PATIENTS WITH GRAVES OPHTHALMOPATHYAND PRETIBIAL MYXEDEMA, Thyroid, 7(1), 1997, pp. 3-12
Several lines of experimental and clinical evidence favor a close etio
logic link between Graves' disease and its associated extrathyroidal m
anifestations, ophthalmopathy and pretibial dermopathy. The human TSHR
represents a candidate antigen shared between the thyroid gland and t
he involved extrathyroidal sites in Graves' disease. Here, we demonstr
ate that ribonucleic acid encoding exons 1-10 of human TSHR can be det
ected in fibroblasts derived from the affected orbital and pretibial s
pace in patients with Graves' ophthalmopathy and pretibial dermopathy.
RNA prepared from cultured fibroblasts was reverse transcribed and th
e resulting cDNA amplified by the polymerase chain reaction using prim
ers spanning exons 1 through 10 of TSHR. The predicted transcripts (18
90 and 2092 bp, respectively) were obtained with cDNA derived from orb
ital and pretibial fibroblasts of all patients with GO and PTM, and or
bital fibroblasts of one healthy individual, and confirmed by southern
hybridization. Sequencing of TSHR transcripts confirmed their identit
y with the reported nucleotide sequence of the human TSHR. Immunostain
ing using both monoclonal and polyclonal antibodies directed against t
he recombinant human TSHR revealed specific TSHR-like immunoreactivity
in fibroblasts and adipose/connective tissue derived from the orbital
and pretibial space of patients with GO and PTD, but not in normal in
dividuals or control tissues. Detection, within the orbital and pretib
ial tissues, of RNA encoding nonvariant hT-SHR and of immunoreactivity
for this important autoantigen in Graves' disease suggests that the p
athogenic role of the TSHR may extend beyond the thyroid gland, and ma
y include the associated extrathyroidal manifestations.